Product Details
| Product Name:
BOC-GLY-OME |
CAS No.:
31954-27-5 |
| Min. Order:
1kg |
Purity:
99% |
| Supply Ability:
Customized |
Release date:
2019/07/06 |
SP1028
| BOC-GLY-OME Basic information |
| Product Name: |
BOC-GLY-OME |
| Synonyms: |
N-[(1,1-Dimethylethoxy)carbonyl]glycine Methyl Ester;N-(tert-Butoxycarbonyl)glycine Methyl ester, 97%+;N-(tert-Butoxycarbonyl)glycine methyl ester 97%;N-(tert-Butoxycarbonyl)glycine Methyl Ester;Boc-glycine methyl ester≥ 98% (GC);N-BOC-Glycine methyleester;METHYL 2-[(TERT-BUTOXYCARBONYL)AMINO]ACETATE;BOC-GLY-OME |
| CAS: |
31954-27-5 |
| MF: |
C8H15NO4 |
| MW: |
189.21 |
| EINECS: |
|
| Product Categories: |
Amino Acid Derivatives;Glycine;Peptide Synthesis;Miscellaneous |
| Mol File: |
31954-27-5.mol |
 |
| |
| BOC-GLY-OME Chemical Properties |
| Boiling point |
190 °C(lit.) |
| density |
1.28 g/mL at 25 °C(lit.) |
| refractive index |
n20/D 1.437(lit.) |
| Fp |
109 °C |
| |
| BOC-GLY-OME Usage And Synthesis |
| Chemical Properties |
Colorless to yellow liquid |
| Uses |
N-[(1,1-Dimethylethoxy)carbonyl]glycine Methyl Ester is a amino acid glycine (G615990) derivative, used widely in various synthetic preparations of pharmaceutical goods and antioxidants. N-[(1,1-Dime thylethoxy)carbonyl]glycine Methyl Ester can be used in the preparation of Pregabalin (P704800), a GABA analogue used as an anticonvulsant. |
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates:
Pharmaceutical intermediates;
OLED intermediates;
You may like
-
CAS:1774-47-6
$7.00 / 1kg
-
-
CAS: 2799-17-9
$7.00 / 1kg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$30.00/500mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-07-20 |
|
|
$0.00/1kg |
VIP3Y
|
Sichuan HongRi Pharma-Tech Co.,Ltd
|
2023-09-25 |
|
|
$0.00/1kg |
VIP4Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-28 |
|
|
$1.00/1g |
|
Sichuan Jiaying Lai Technology Co.,LTD
|
2019-07-21 |